HIGHLIGHTS
- who: Fereshteh Ameli from the This retrospective-observational study was performed on , confirmed MCL patients based on immunohistochemistry (IHC)Specimens were obtained from the archives of surgical pathology departments of Imam Khomeini Hospital Complex and Shariati hospitals, affiliated to Tehran University of Medical Science and Namazee hospital affiliated to Shiraz University of have published the research: Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma, in the Journal: (JOURNAL)
- what: This study aimed to determine PD-1/ PD-L1 expression in MCL specimens and its significance as an immune check point . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.